Michael Auerbach - 10 Sep 2021 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Director
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
10 Sep 2021
Net transactions value
$0
Form type
4
Filing time
13 Sep 2021, 16:30:24 UTC
Previous filing
24 Jun 2021
Next filing
08 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +128,000 $0.000000 128,000 10 Sep 2021 Common Shares 128,000 $16.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest with respect to a third of the underlying common shares on June 17, 2022 and in 24 substantially equal monthly installments thereafter until June 17, 2024.